Foreword / Ezzeddine Boutrif, Jorgen Schlundt -- Background and objectives -- Epidemiology and public health

aspects -- Organisms of concern -- Enterobacter sakazakii -- Other relevant organisms of concern --

Scope/Case description -- Identification of products considered -- Case definition -- Hazard identification --

Category A organisms - Clear evidence of causality -- Category B organisms - Causality plausible, but not

yet demonstrated -- Category C organisms - Causality less plausible or not yet demonstrated -- hazard

characterization -- Populations at risk -- Dose-response -- Exposure assessment -- Exposure to infant

formula/breatfeeding rates -- Developing countries -- Microbial aspects of manufacture and use of powdered

infant formula -- Manufacture -- Control of ingredient quality -- Processing -- Post-processing and packaging

-- hazard aalysis critical control point (HCCCP) in The manufacture of powdered infant formula -- Monitoring

-- Microbiologial specifications -- Reconstitution and use -- Labelling and preparation -- Storage and

handling of prepared formula -- Education -- Risk characterization -- Approaches and outputs -- Evaluation of

potential risk reduction options for formula-fed infants -- Ris reduction strategies for formula-fed infants

-- reducing The concentration/Prevalence of instrinsic contamination of powdered infant formula by E.

sakazakii -- Reducing the level of contamination throught heating reconstituted powdered infant formula prior

to use -- Minimizing the chance of contamination of reconstituted formula during preparation -- Minimizing the

grwth of E. sakazakii following reconstitution pior to consumption -- Key findings and recommendations -- To

membert countries, NGOs, FAO and WHO -- To Codex (e.g. CCFH) -- To member countries, FAO, WHO,Codex and NGOs

-- To FAO, WHO and the scientific community -- Lis of background papers -- Data received in response to the FA

FAO/WHO call for data -- Risk assessment --